---
figid: PMC3376977__onci-1-38-g2
figlink: /pmc/articles/PMC3376977/figure/F2/
number: ''
caption: 'Figure 2. Tumors parameters implicated in the activation of NK cells. In
  RCC, VHL mutations induce constitutive activation and accumulation of Hypoxia-inducible
  factor (HIF). Certain VHL mutations correlate with low HLA-I molecules expression
  via a partially HIF-dependent pathway. The low expression of HLA-I molecules by
  VHL-mutated RCC cells reduces the engagement of NKG2A inhibitory receptor, shifting
  the balance toward NK cell activation. Membrane HLA-G molecules upregulate inhibitory
  receptors (NKG2A,and ILT2) on NK cells. Membrane-bound IL15 (Mb-IL15) is involved
  in NK cell activation and survival. In CML, the oncogeneic protein bcr/abl induces
  the expression of ICAM-1 and NKG2D ligands on myeloid cells favoring NK/target conjugates
  and lysis. Altered IFNγ signaling in bcr/abl target maintains a low HLA-I molecules
  expression. Bcr/abl dendritic cells activate NK cells via NKG2D receptor. Imatinib
  mesylate interferes with NK/leukemic targets. DC: Dendritic cell; IM: Imatinib Mesylate;
  IRF: Interferon regulatory factor; STAT-1: Signal Transducer and Activator of Transcription
  factor-1.'
pmcid: PMC3376977
papertitle: NK cells sense tumors, course of disease and treatments.
reftext: Giulia Fregni, et al. Oncoimmunology. 2012 Jan 1;1(1):38-47.
pmc_ranked_result_index: '19493'
pathway_score: 0.6793189
filename: onci-1-38-g2.jpg
figtitle: NK cells sense tumors, course of disease and treatments
year: '2012'
organisms: Homo sapiens
ndex: 23440d84-df33-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3376977__onci-1-38-g2.html
  '@type': Dataset
  description: 'Figure 2. Tumors parameters implicated in the activation of NK cells.
    In RCC, VHL mutations induce constitutive activation and accumulation of Hypoxia-inducible
    factor (HIF). Certain VHL mutations correlate with low HLA-I molecules expression
    via a partially HIF-dependent pathway. The low expression of HLA-I molecules by
    VHL-mutated RCC cells reduces the engagement of NKG2A inhibitory receptor, shifting
    the balance toward NK cell activation. Membrane HLA-G molecules upregulate inhibitory
    receptors (NKG2A,and ILT2) on NK cells. Membrane-bound IL15 (Mb-IL15) is involved
    in NK cell activation and survival. In CML, the oncogeneic protein bcr/abl induces
    the expression of ICAM-1 and NKG2D ligands on myeloid cells favoring NK/target
    conjugates and lysis. Altered IFNγ signaling in bcr/abl target maintains a low
    HLA-I molecules expression. Bcr/abl dendritic cells activate NK cells via NKG2D
    receptor. Imatinib mesylate interferes with NK/leukemic targets. DC: Dendritic
    cell; IM: Imatinib Mesylate; IRF: Interferon regulatory factor; STAT-1: Signal
    Transducer and Activator of Transcription factor-1.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HIF3A
  - ARNT
  - ICAM1
  - ARNT2
  - HLA-G
  - TRIM63
  - MTTP
  - BCR
  - ARNTL
  - IFNG
  - MUT
  - STAT1
  - EPAS1
  - LILRB1
  - HIF1A
  - VHL
  - XRCC1
  - KLRC1
genes:
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: HIF3A
  entrez: '64344'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNT
  entrez: '405'
- word: ICAM-1
  symbol: ICAM1
  source: hgnc_symbol
  hgnc_symbol: ICAM1
  entrez: '3383'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNT2
  entrez: '9915'
- word: HLA-G
  symbol: HLA-G
  source: hgnc_symbol
  hgnc_symbol: HLA-G
  entrez: '3135'
- word: IRF
  symbol: IRF
  source: hgnc_alias_symbol
  hgnc_symbol: TRIM63
  entrez: '84676'
- word: bcr/abl
  symbol: ABL
  source: hgnc_alias_symbol
  hgnc_symbol: MTTP
  entrez: '4547'
- word: bcr/abl
  symbol: BCR
  source: hgnc_symbol
  hgnc_symbol: BCR
  entrez: '613'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNTL
  entrez: '406'
- word: IFNY
  symbol: IFNG
  source: hgnc_symbol
  hgnc_symbol: IFNG
  entrez: '3458'
- word: mut
  symbol: MUT
  source: hgnc_symbol
  hgnc_symbol: MUT
  entrez: '4594'
- word: STAT-1
  symbol: STAT1
  source: hgnc_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: EPAS1
  entrez: '2034'
- word: NKG2A/ILT2
  symbol: ILT2
  source: hgnc_alias_symbol
  hgnc_symbol: LILRB1
  entrez: '10859'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: VHL
  symbol: VHL
  source: hgnc_symbol
  hgnc_symbol: VHL
  entrez: '7428'
- word: RCC
  symbol: RCC
  source: hgnc_prev_symbol
  hgnc_symbol: XRCC1
  entrez: '7515'
- word: NKG2A/ILT2
  symbol: NKG2-A
  source: hgnc_alias_symbol
  hgnc_symbol: KLRC1
  entrez: '3821'
chemicals: []
diseases: []
---
